Not all trials are built the same.
Here, Drs. Gradishar and Traina walk through the key design differences in ASCENT-03 vs. TROPION-Breast02, including crossover, disease-free interval caps, chemotherapy selection, and how these factors influence progression-free survival and trial interpretation.
A critical discussion for clinicians comparing data across studies.
